Abstract
THE disease non-insulin-dependent (type 2) diabetes mellitus (NIDDM) is characterized by abnormally high blood glucose resulting from a relative deficiency of insulin1. It affects about 2% of the world's population and treatment of diabetes and its complications are an increasing health-care burden2. Genetic factors are important in the aetiology of NIDDM, and linkage studies are starting to localize some of the genes that influence the development of this disorder3. Maturity-onset diabetes of the young (MODY), a single-gene disorder responsible for 2–5% of NIDDM, is characterized by autosomal dominant inheritance and an age of onset of 25 years or younger4–6. MODY genes have been localized to chromosomes 7, 12 and 20 (refs 5, 7, 8) and clinical studies indicate that mutations in these genes are associated with abnormal patterns of glucose-stimulated insulin secretion1,9. The gene on chromosome 7 (MODY2) encodes the glycolytic enzyme glucokinase5 which plays a key role in generating the metabolic signal for insulin secretion and in integrating hepatic glucose uptake. Here we show that subjects with the MODY3-form of NIDDM have mutations in the gene encoding hepatocyte nuclear factor-1α (HNF-1α, which is encoded by the gene TCF1). HNF-1α is a transcription factor that helps in the tissue-specific regulation of the expression of several liver genes10,11 and also functions as a weak transactivator of the rat insulin-I gene12.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Polonsky, K. S. Diabetes 44, 705–717 (1995).
McCarty, D. S. & Zimmet, P. Diabetes 1994 to 2010: Global Estimates and Projections (International Diabetes Institute, Melbourne, Australia, 1994).
Hanis, C. L. et al. Nature Genet. 13, 161–166 (1996).
Fajans, S. S. Diabetes/Metabol. Rev. 5, 579–606 (1989).
Froguel, P. et al. N. Engl. J. Med. 328, 697–702 (1993).
Ledermann, H. M. Lancet 345, 648 (1995).
Bell, G. I. et al. Proc. Natl Acad. Sci. USA 88, 1484–1488 (1991).
Vaxillaire, M. et al. Nature Genet. 9, 418–423 (1995).
Byrne, M. M. et al. Diabetes 45, 1503–1510 (1996).
Frain, M. et al. Cell 59, 145–157 (1989).
Tronche, F. & Yaniv, M. Bioessays 14, 579–587 (1992).
Emens, L. A., Landers, D. W. & Moss, L. G. Proc. Natl Acad. Sci. USA 89, 7300–7304 (1992).
Menzel, S. et al. Diabetes 44, 1408–1413 (1995).
Chumakov, I. M. et al. Nature 377 (suppl.), 175–297 (1995).
Hudson, T. J. et al. Science 270, 1945–1954 (1994).
Church, D. M. et al. Nature Genet. 6, 98–105 (1994).
Korn, B. et al. Hum. Mol. Genet. 1, 235–242 (1992).
Kenny, S. J., Aubert, R. E. & Geiss, L. S. in Diabetes in America 2nd edn (eds National Diabetes Data Group) 47–67 (NIH publication no. 95-1468, 1995).
Mendel, D. B., Hansen, L. P., Graves, M. K., Conley, P. B. & Crabtree, G. R. Genes Dev. 5, 1042–1056 (1991).
Herskowitz, I. Nature 329, 219–222 (1987).
Pontoglio, M. et al. Cell 84, 575–585 (1996).
Lesage, S. et al. Diabetes 44, 1243–1247 (1995).
Mahtani, M. et al. Nature Genet. 14, 90–94 (1996).
Byrne, M. M., Sturis, J., Sobel, R. J. & Polonsky, K. S. Am. J. Physiol. 270, E572–E579 (1996).
Yamagata, K. et al. Nature 384, 458–460 (1996).
Kuo, C. J. et al. Nature 355, 457–461 (1992).
Bach, I. et al. Genomics 8, 155–164 (1990).
Bach, I. & Yaniv, M. EMBO J. 12, 4229–4242 (1993).
Bach, I., Pontoglio, M. & Yaniv, M. Nucleic Acids Res. 20, 4199–4204 (1992).
Hörlein, A., Grajer, K.-H. & Igo-Kemenes, T. Biol. Chem. Hoppe-Seyler 374, 419–425 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamagata, K., Oda, N., Kaisaki, P. et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455–458 (1996). https://doi.org/10.1038/384455a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/384455a0
This article is cited by
-
Monogenic diabetes
Nature Reviews Disease Primers (2023)
-
Where to for precision treatment of HNF1A-MODY?
Diabetologia (2022)
-
Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes
Journal of Endocrinological Investigation (2022)
-
Precision diabetes is becoming a reality in India
Proceedings of the Indian National Science Academy (2022)
-
A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY
Diabetologia (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.